Of note, CD62L stimulation indexes in NK cells, monocytes and granulocytes were lower in RA treated patients in comparison with naïve and healthy donors, suggesting a less potent effect of IFX in this cohort. The gene discussed is SELL; the disease is rheumatoid arthritis.